A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
This panel explores the dynamic realm of leading-edge technologies within the fertility market. Speakers include Steve Shum, CEO at INVO Bioscience and David Wolf, CEO at Hamilton Thorne Ltd. This KOL Panel was recorded during the Lytham Partners Fall 2023 Investor...
INVO Bioscience is a healthcare services fertility company dedicated to expanding the assisted reproductive technology ("ART") marketplace by making fertility care accessible and inclusive to people around the world. Our commercialization strategy is focused on the...
During this fireside chat we welcome INVO Bioscience, ticker symbol of INVO on the NASDAQ and their CEO, Mr. Steve Shum. INVO is a healthcare services fertility company dedicated to expanding the assisted reproductive technology ("ART") marketplace by making fertility...